Total Payments
$201,443
2024 Payments
$33,277
Companies
16
Transactions
142
Medicare Patients
1,344
Medicare Billing
$128,585
Payment Breakdown by Category
Consulting$97,988 (48.6%)
Travel$63,905 (31.7%)
Other$34,550 (17.2%)
Food & Beverage$4,122 (2.0%)
Research$739.39 (0.4%)
Education$138.00 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $97,988 | 28 | 48.6% |
| Travel and Lodging | $63,905 | 41 | 31.7% |
| Honoraria | $24,167 | 5 | 12.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $10,383 | 4 | 5.2% |
| Food and Beverage | $4,122 | 58 | 2.0% |
| Unspecified | $739.39 | 2 | 0.4% |
| Education | $138.00 | 4 | 0.1% |
Payments by Type
General
$200,704
140 transactions
Research
$739.39
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| CSL Behring | $67,093 | 46 | $0 (2024) |
| Regeneron Pharmaceuticals, Inc. | $48,074 | 40 | $0 (2024) |
| Astellas Pharma Inc | $36,903 | 10 | $0 (2020) |
| ARGENX US, INC. | $22,200 | 5 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $15,259 | 6 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $6,779 | 9 | $0 (2024) |
| PFIZER INC. | $2,750 | 1 | $0 (2024) |
| F. Hoffmann-La Roche AG | $1,313 | 2 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $274.34 | 3 | $0 (2018) |
| Veloxis Pharmaceuticals, Inc. | $217.99 | 4 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $33,277 | 18 | Mallinckrodt Hospital Products Inc. ($15,259) |
| 2023 | $59,607 | 26 | Regeneron Pharmaceuticals, Inc. ($23,075) |
| 2022 | $19,408 | 16 | CSL Behring ($14,887) |
| 2021 | $1,936 | 2 | Regeneron Pharmaceuticals, Inc. ($1,936) |
| 2020 | $52,749 | 19 | Astellas Pharma Inc ($36,903) |
| 2019 | $21,267 | 38 | CSL Behring ($17,454) |
| 2018 | $11,501 | 12 | CSL Behring ($11,229) |
| 2017 | $1,698 | 11 | F. Hoffmann-La Roche AG ($1,313) |
All Payment Transactions
142 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Regeneron Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,420.00 | General |
| 12/09/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Consulting Fee | Cash or cash equivalent | $3,600.00 | General |
| Category: Neurology | ||||||
| 11/20/2024 | E.R. Squibb & Sons, L.L.C. | NULOJIX (Biological) | Food and Beverage | Cash or cash equivalent | $149.40 | General |
| Category: Immunology | ||||||
| 11/05/2024 | E.R. Squibb & Sons, L.L.C. | NULOJIX (Biological) | Food and Beverage | Cash or cash equivalent | $22.65 | General |
| Category: Immunology | ||||||
| 11/05/2024 | E.R. Squibb & Sons, L.L.C. | NULOJIX (Biological) | Food and Beverage | Cash or cash equivalent | $1.89 | General |
| Category: Immunology | ||||||
| 08/23/2024 | Regeneron Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,420.00 | General |
| 07/17/2024 | ARGENX US, INC. | — | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| 06/01/2024 | SANOFI-AVENTIS U.S. LLC | — | Food and Beverage | In-kind items and services | $134.65 | General |
| 05/31/2024 | CSL Behring | — | Consulting Fee | Cash or cash equivalent | $1,800.00 | General |
| 05/15/2024 | Mallinckrodt Hospital Products Inc. | UVADEX (Drug) | Consulting Fee | Cash or cash equivalent | $13,750.00 | General |
| Category: CRITICAL CARE | ||||||
| 05/14/2024 | SANOFI-AVENTIS U.S. LLC | THYMOGLOBULIN (Biological) | Food and Beverage | In-kind items and services | $119.02 | General |
| Category: Oncology | ||||||
| 04/25/2024 | Mallinckrodt Hospital Products Inc. | CELLEX (Device) | Consulting Fee | Cash or cash equivalent | $103.42 | General |
| Category: CRITICAL CARE | ||||||
| 03/21/2024 | Mallinckrodt Hospital Products Inc. | CELLEX (Device) | Travel and Lodging | In-kind items and services | $725.21 | General |
| Category: CRITICAL CARE | ||||||
| 03/21/2024 | Mallinckrodt Hospital Products Inc. | CELLEX (Device) | Travel and Lodging | In-kind items and services | $250.81 | General |
| Category: CRITICAL CARE | ||||||
| 03/21/2024 | Mallinckrodt Hospital Products Inc. | CELLEX (Device) | Travel and Lodging | In-kind items and services | $216.64 | General |
| Category: CRITICAL CARE | ||||||
| 03/21/2024 | Mallinckrodt Hospital Products Inc. | CELLEX (Device) | Food and Beverage | In-kind items and services | $212.95 | General |
| Category: CRITICAL CARE | ||||||
| 01/17/2024 | ARGENX US, INC. | VYVGART (Drug) | Consulting Fee | Cash or cash equivalent | $6,000.00 | General |
| Category: Immunology | ||||||
| 01/03/2024 | PFIZER INC. | ATGAM (Biological) | Consulting Fee | Cash or cash equivalent | $2,750.00 | General |
| Category: HEMATOLOGY | ||||||
| 10/13/2023 | SANOFI-AVENTIS U.S. LLC | — | Consulting Fee | Cash or cash equivalent | $4,382.00 | General |
| 10/13/2023 | SANOFI-AVENTIS U.S. LLC | — | Travel and Lodging | In-kind items and services | $970.98 | General |
| 10/13/2023 | SANOFI-AVENTIS U.S. LLC | — | Travel and Lodging | In-kind items and services | $480.05 | General |
| 10/13/2023 | SANOFI-AVENTIS U.S. LLC | — | Food and Beverage | In-kind items and services | $354.06 | General |
| 10/13/2023 | SANOFI-AVENTIS U.S. LLC | — | Travel and Lodging | In-kind items and services | $154.41 | General |
| 08/22/2023 | SANOFI-AVENTIS U.S. LLC | — | Food and Beverage | In-kind items and services | $114.32 | General |
| 05/23/2023 | ARGENX US, INC. | VYVGART (Drug) | Consulting Fee | Cash or cash equivalent | $8,400.00 | General |
| Category: Immunology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| REGN5458 Clinical Development Program | Regeneron Pharmaceuticals, Inc. | $739.39 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 244 | 308 | $85,448 | $20,451 |
| 2022 | 6 | 352 | 474 | $149,959 | $37,581 |
| 2021 | 5 | 330 | 441 | $128,115 | $36,674 |
| 2020 | 5 | 418 | 503 | $139,597 | $33,878 |
Total Patients
1,344
Total Services
1,726
Medicare Billing
$128,585
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 92 | 124 | $39,760 | $9,039 | 22.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 101 | 125 | $27,308 | $6,627 | 24.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 19 | 26 | $6,104 | $1,764 | 28.9% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 20 | 21 | $6,624 | $1,667 | 25.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 12 | $5,652 | $1,354 | 24.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 122 | 169 | $54,177 | $13,667 | 25.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 116 | 136 | $29,508 | $7,407 | 25.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 40 | 84 | $27,680 | $7,302 | 26.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 24 | 25 | $15,930 | $4,200 | 26.4% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 32 | 38 | $12,229 | $2,798 | 22.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 18 | 22 | $10,435 | $2,208 | 21.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 135 | 188 | $55,654 | $16,218 | 29.1% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 71 | 97 | $27,626 | $7,886 | 28.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 34 | 45 | $19,932 | $5,633 | 28.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 72 | 84 | $15,813 | $4,527 | 28.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 18 | 27 | $9,090 | $2,411 | 26.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 184 | 240 | $61,440 | $16,278 | 26.5% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 90 | 96 | $34,656 | $7,587 | 21.9% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 65 | 76 | $25,724 | $5,294 | 20.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 68 | 76 | $12,692 | $3,340 | 26.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 11 | 15 | $5,085 | $1,379 | 27.1% |
About Dr. Stanley Jordan, MD
Dr. Stanley Jordan, MD is a Internal Medicine healthcare provider based in West Hollywood, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1669432167.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stanley Jordan, MD has received a total of $201,443 in payments from pharmaceutical and medical device companies, with $33,277 received in 2024. These payments were reported across 142 transactions from 16 companies. The most common payment nature is "Consulting Fee" ($97,988).
As a Medicare-enrolled provider, Jordan has provided services to 1,344 Medicare beneficiaries, totaling 1,726 services with total Medicare billing of $128,585. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Nephrology
- Location West Hollywood, CA
- Active Since 03/27/2006
- Last Updated 01/08/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1669432167
Products in Payments
- TACROLIMUS (Drug) $36,903
- VYVGART (Drug) $14,400
- UVADEX (Drug) $13,750
- VYVGART HYTRULO (Drug) $3,600
- ATGAM (Biological) $2,750
- CELLEX (Device) $1,509
- GAZYVA (Biological) $1,313
- Envarsus (Drug) $189.37
- NULOJIX (Biological) $173.94
- ZORTRESS (Drug) $156.26
- THYMOGLOBULIN (Biological) $119.02
- Berinert (Biological) $117.50
- Rituxan (Biological) $106.07
- Veltassa (Drug) $106.01
- JEVTANA (Drug) $69.99
- SOLIRIS (Drug) $68.01
- Berinert 500U (Biological) $46.99
- KRYSTEXXA (Biological) $42.11
- Envarsus XR (Drug) $28.62
- ULTOMIRIS (Drug) $19.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in West Hollywood
Anthony Mills, Md, MD
Internal Medicine — Payments: $510,976
Internal Medicine $510,976
Dr. Andrew Hendifar, Md, Mph, MD, MPH
Internal Medicine — Payments: $290,268
Internal Medicine $290,268
Dr. Michael Shehata, M.d, M.D
Internal Medicine — Payments: $279,189
Internal Medicine $279,189
Dr. Barham Abu Dayyeh, Md, MD
Internal Medicine — Payments: $173,790
Internal Medicine $173,790
Dr. Rabindra Watson, M.d, M.D
Internal Medicine — Payments: $157,237
Internal Medicine $157,237
Phillip Gu, Md, MD
Internal Medicine — Payments: $80,698
Internal Medicine $80,698